论文部分内容阅读
目的了解广州市乙型肝炎(乙肝)相关疾病患者一年直接经济负担,探讨其影响因素。方法利用自制结构式问卷对住院患者进行面对面调查并结合查阅病案的方法获取患者门诊和住院等相关花费;采用多元逐步回归对影响因素进行分析。结果调查所得广州市564例乙肝相关疾病患者年例均直接经济负担为41 242.9元;直接医疗费用和直接非医疗费用分别为39 097.9元和2 145.0元;直接医疗费用大于直接非医疗费用,住院费用大于门诊费用;合并疾病种类、医院类型、是否抗病毒治疗和乙肝相关疾病类型是直接经济负担主要影响因素。结论直接医疗费用占直接费用的绝大部分,直接费用对乙肝相关疾病患者及家庭影响较大,降低住院费用、控制乙肝进程、延缓疾病发展可有效降低直接费用,节省医疗资源。
Objective To understand the direct economic burden of Hepatitis B (Hepatitis B) related diseases in Guangzhou and to explore the influencing factors. Methods Self-made structured questionnaires were used to investigate the outpatient and inpatient costs of hospitalized patients by face-to-face investigation combined with the access to medical records. The influencing factors were analyzed by multivariate stepwise regression. Results Among the 564 HBV-related diseases in Guangzhou, the direct economic burden was 41 242.9 yuan per year. The direct medical costs and direct non-medical expenses were 39 097.9 yuan and 2 145.0 yuan respectively. The direct medical costs were higher than direct non-medical expenses and hospitalization Expenses are greater than outpatient costs; types of mergers, types of hospitals, whether antiviral treatments and types of hepatitis B-related diseases are the major contributors to the direct economic burden. Conclusion Direct medical costs account for the vast majority of direct costs. Direct costs have a greater impact on patients with hepatitis B-related diseases and their families, reduce hospitalization costs, control the progress of hepatitis B and delay the development of diseases, which can effectively reduce direct costs and save medical resources.